Recombinant multi-species GNAI1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine GNAI1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Guanine nucleotide binding proteins are heterotrimeric signal-transducing molecules consisting of alpha, beta, and gamma subunits. The alpha subunit binds guanine nucleotide, can hydrolyze GTP, and can interact with other proteins. The protein encoded by this gene represents the alpha subunit of an inhibitory complex. The encoded protein is part of a complex that responds to beta-adrenergic signals by inhibiting adenylate cyclase. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2012]
The Alternative Names of target: Adenylate cyclase-inhibiting G alpha protein,BPGTPB,GNAI1,Gi,Gialpha1,Gnai-1,Gnai1,Guanine nucleotide-binding protein G(i) subunit alpha-1,HG1B,Hg1b,NEDHISB
Go
to GNAI1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP7521-Ag-1/ GM-Tg-hg-IP7521-Ag-2 | Human GNAI1 protein | Human |
| GM-Tg-rg-IP7521-Ag-1/ GM-Tg-rg-IP7521-Ag-2 | Rat GNAI1 protein | Rat |
| GM-Tg-mg-IP7521-Ag-1/ GM-Tg-mg-IP7521-Ag-2 | Mouse GNAI1 protein | Mouse |
| GM-Tg-cynog-IP7521-Ag-1/ GM-Tg-cynog-IP7521-Ag-2 | Cynomolgus/Rhesus macaque GNAI1 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP7521-Ag-1/ GM-Tg-felg-IP7521-Ag-2 | Feline GNAI1 protein | Feline |
| GM-Tg-cang-IP7521-Ag-1/ GM-Tg-cang-IP7521-Ag-2 | Canine GNAI1 protein | Canine |
| GM-Tg-bovg-IP7521-Ag-1/ GM-Tg-bovg-IP7521-Ag-2 | Bovine GNAI1 protein | Bovine |
| GM-Tg-equg-IP7521-Ag-1/ GM-Tg-equg-IP7521-Ag-2 | Equine GNAI1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP7521-Ag-1/ GM-Tg-hg-IP7521-Ag-2;
GM-Tg-rg-IP7521-Ag-1/ GM-Tg-rg-IP7521-Ag-2;
GM-Tg-mg-IP7521-Ag-1/ GM-Tg-mg-IP7521-Ag-2; GM-Tg-cynog-IP7521-Ag-1/ GM-Tg-cynog-IP7521-Ag-2; GM-Tg-felg-IP7521-Ag-1/ GM-Tg-felg-IP7521-Ag-2; GM-Tg-cang-IP7521-Ag-1/ GM-Tg-cang-IP7521-Ag-2; GM-Tg-bovg-IP7521-Ag-1/ GM-Tg-bovg-IP7521-Ag-2; GM-Tg-equg-IP7521-Ag-1/ GM-Tg-equg-IP7521-Ag-2 |
| Products Name | GNAI1 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | GNAI1 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine GNAI1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.